Clinical trial

A Comparison of the Effectiveness and Safety of ULTRACET® (Tramadol…

NCT00236483 · Johnson & Johnson Pharmaceutical Research & Development, L.L.C., Industry · Completed

Key facts

NCT number NCT00236483
Title A Comparison of the Effectiveness and Safety of ULTRACET® (Tramadol Hydrochloride/Acetaminophen) Versus ULTRAM® (Tramadol Hydrochloride) Versus Placebo in Patients With Pain After Oral Surgery
Official title A Comparison of the Efficacy and Safety of ULTRACET® (Tramadol HCl/Acetaminophen) Versus ULTRAM® (Tramadol HCl) Versus Placebo in Subjects With Pain Following Oral Surgery
Lead sponsor Johnson & Johnson Pharmaceutical Research & Development, L.L.C., Industry
Collaborators PriCara, Unit of Ortho-McNeil, Inc. Industry
Status Completed
Phase Phase 4
Study type Interventional
Conditions Surgery, Oral, Pain, Postoperative
Intervention type Drug
Interventions tramadol hydrochloride + acetaminophen
Enrollment 456
Start date Nov 1, 2002
Completion Feb 1, 2003
First posted Oct 12, 2005
Last update posted Jun 10, 2011

At a glance

  • No Results posted
  • None Linked FDA submissions

Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.

About ClinicalTrials.gov studies

ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.

Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date:

Browse all ClinicalTrials.gov studies